SONYA GUNTER: Open Payments
NPI 1063257335 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $215 |
| ABBVIE INC. | 3 | $158 |
| Teva Pharmaceuticals USA, Inc. | 3 | $148 |
| Eisai Inc. | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $63 |
| Ardelyx, Inc. | 3 | $53 |
| PFIZER INC. | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Solventum Corporation | 1 | $24 |
Products named: AUSTEDO XR, Rystiggo, Leqembi, QULIPTA, INGREZZA, IBSRELA, ENTYVIO, Briviact.
Industry payments across FL — which companies pay providers there.
